Gland Pharma Key Metrics

BSE: 543245 | NSE: GLAND | ISIN: INE068V01023 | Sector: Biotechnology & Drugs

1,785.00 +28.45 (1.62%)Updated : 25 Nov 2024

Ratios

Return on average equity - 5 year average	14.89
Net Income/employee - trailing 12 month	16,39,955.00
Revenue/employee - most recent fiscal year	1,28,71,440.00
Return on investment - most recent fiscal year	8.92
Return on average assets - most recent fiscal year	7.95
Receivables turnover - most recent fiscal year	4.16
Return on investment - trailing 12 month	7.65
Return on average assets - trailing 12 month	6.54
Inventory turnover - most recent fiscal year	1.22
Inventory turnover - trailing 12 month	1.28
Revenue/employee - trailing 12 month	1,39,67,630.00
Return on average assets - 5 year average	13.23
Net Income/employee - most recent fiscal year	17,55,192.00
Return on average equity - trailing 12 month	8.09
Receivables turnover - trailing 12 month	4.11
Asset turnover - most recent fiscal year	0.58
Asset turnover - trailing 12 month	0.56
Return on average equity - most recent fiscal year	9.26
Return on investment - 5 year average	14.56